Our Services
Investigator-Initiated Studies in China
Bridging East and West to advance early clinical insight through managed partnerships with established Chinese CRO and CMC partners.
China / 01
A Managed Partnership Model
TCR-Solutions helps biotech and pharma sponsors evaluate investigator-initiated study opportunities in China through a managed partnership model.
We work with established Chinese CRO and CMC partners on behalf of sponsors, providing strategic guidance, coordination and oversight throughout.
This approach gives sponsors access to large, treatment-naïve patient populations and high-quality investigator sites, while maintaining the governance and quality standards expected by Western regulators.
China / 02
Strategic Guidance and Oversight
Our team provides end-to-end strategic guidance — from initial feasibility assessment and partner selection through to study design, regulatory engagement, and ongoing quality oversight.
We ensure that every investigator-initiated study is aligned with your broader clinical development strategy and meets the standards required for global regulatory submissions.
